{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:28:09Z","timestamp":1791052089890,"version":"4.1.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":137,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.vaccine.2012.05.050","type":"journal-article","created":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T04:05:49Z","timestamp":1338523549000},"page":"1680-1694","source":"Crossref","is-referenced-by-count":63,"title":["Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data"],"prefix":"10.1016","volume":"31","author":[{"given":"G.S.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"July (RR11)","key":"10.1016\/j.vaccine.2012.05.050_bib0005","first-page":"1","article-title":"Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP)","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2012.05.050_bib0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0015","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1016\/S0264-410X(03)00459-6","article-title":"Incidence of herpes-zoster among children and adolescents in a community with moderate varicella vaccination coverage","volume":"21","author":"Goldman","year":"2003","journal-title":"Vaccine"},{"issue":"July\/August (4)","key":"10.1016\/j.vaccine.2012.05.050_bib0020","first-page":"203","article-title":"Universal varicella vaccination: efficacy trends and effect on herpes zoster","volume":"24","author":"Goldman","year":"2005","journal-title":"Int J Toxicol"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2012.05.050_bib0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1542\/peds.76.4.512","article-title":"Epidemiology of herpes zoster in children and adolescents: a population-based study","volume":"76","author":"Guess","year":"1985","journal-title":"Pediatrics"},{"issue":"August (15)","key":"10.1016\/j.vaccine.2012.05.050_bib0030","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archinte.1995.00430150071008","article-title":"The incidence of herpes zoster","volume":"155","author":"Donahue","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0035","first-page":"9","article-title":"The nature of herpes zoster: a long term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1995","journal-title":"Proc R Soc Med"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2012.05.050_bib0040","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine (Baltimore)"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0045","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.vaccine.2012.05.050_bib0050","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992\u20132002","volume":"191","author":"Jumaan","year":"2005","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2012.05.050_bib0055","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1086\/430328","article-title":"Changing dynamics of varicella-zoster virus infections in the 21st century: the impact of vaccination","volume":"191","author":"Whitley","year":"2005","journal-title":"J Infect Dis"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","article-title":"Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination","volume":"52","author":"Leung","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2012.05.050_bib0065","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","article-title":"Population-based incidence of herpes zoster after introduction a publicly funded varicella vaccination program","volume":"29","author":"Tanuseputro","year":"2011","journal-title":"Vaccine"},{"issue":"August (Suppl. 1)","key":"10.1016\/j.vaccine.2012.05.050_bib0070","first-page":"S67","article-title":"The impact of vaccination on varicella incidence, conditional on school attendance and temperature","volume":"9","author":"Goldman","year":"2000","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0075","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1542\/peds.109.6.1068","article-title":"Second varicella infections: are they more common than previously thought?","volume":"109","author":"Hall","year":"2002","journal-title":"Pediatrics"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.05.050_bib0080","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1086\/522144","article-title":"Varicella outbreak epidemiology in an active surveillance site, 1995\u20132005","volume":"197","author":"Civen","year":"2008","journal-title":"J Infect Dis"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2012.05.050_bib0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/315714","article-title":"Varicella mortality: trends before vaccine licensure in the United States, 1970\u20131994","volume":"182","author":"Meyer","year":"2000","journal-title":"J Infect Dis"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0090","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1542\/peds.2011-0017","article-title":"Varicella in infants after implementation of the US varicella vaccination program","volume":"128","author":"Chaves","year":"2011","journal-title":"Pediatrics"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00006454-200106000-00014","article-title":"Update on varicella","volume":"20","author":"Seward","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"August (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0100","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.292.6.704","article-title":"Contagiousness of varicella in vaccinated cases: a household contact study","volume":"292","author":"Seward","year":"2004","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2012.05.050_bib0105","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1086\/522143","article-title":"Knowledge, attitudes, and practices regarding varicella vaccination among health care providers participating in the Varicella Active Surveillance Project, Antelope Valley, California, 2005","volume":"197","author":"Carbajal","year":"2008","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.05.050_bib0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.inf.0000195637.45481.96","article-title":"Commentary: the case for universal varicella immunization","volume":"25","author":"Seward","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"October (9544)","key":"10.1016\/j.vaccine.2012.05.050_bib0115","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2012.05.050_bib0120","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.05.050_bib0125","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/522146","article-title":"Epidemiology of varicella hospitalizations in the United States, 1995\u20132005","volume":"197","author":"Reynolds","year":"2008","journal-title":"J Infect Dis"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.05.050_bib0130","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.05.050_bib0135","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US vaccination program: a review","volume":"197","author":"Seward","year":"2008","journal-title":"J Infect Dis"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.05.050_bib0140","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1086\/522155","article-title":"Varicella among adults: data from an active surveillance project, 1995\u20132005","volume":"197","author":"Marin","year":"2008","journal-title":"J Infect Dis"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.05.050_bib0145","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites\u2014United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2012.05.050_bib0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0155","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1016\/S0264-410X(03)00461-4","article-title":"Varicella susceptibility and incidence of herpes zoster among children and adolescents in a community under active surveillance","volume":"21","author":"Goldman","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0160","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1016\/S0264-410X(03)00458-4","article-title":"Using capture\u2013recapture methods to assess varicella incidence in a community under active surveillance","volume":"21","author":"Goldman","year":"2003","journal-title":"Vaccine"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2012.05.050_bib0165","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1016\/j.vaccine.2004.03.064","article-title":"Scientific commentary","volume":"22","author":"Jumaan","year":"2004","journal-title":"Vaccine"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2012.05.050_bib0170","first-page":"3232","article-title":"Response to letter to editor by Jumaan: Goldman's role in the Varicella Active Surveillance Project","volume":"22","author":"Goldman","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/10915810600870591","article-title":"The case against universal varicella vaccination","volume":"25","author":"Goldman","year":"2006","journal-title":"Int J Toxicol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.05.050_bib0180","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/INF.0b013e3181a90b16","article-title":"The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination","volume":"28","author":"Civen","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2012.05.050_bib0185","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1073\/pnas.93.14.7231","article-title":"Mass vaccination to control chickenpox: the influence of zoster","volume":"93","author":"Ferguson","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0190","first-page":"100","article-title":"Direct costs attributed to chickenpox and herpes zoster in British Columbia 1992 to 1996","volume":"25","author":"Baker","year":"1999","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0195","unstructured":"Maupin T, Peterson C, Mascola L. 2002, 2003 Annual Summary, Antelope Valley Varicella Active Surveillance Project (VASP), Los Angeles County Department of Health Services (LADHS), Centers for Disease Control and Prevention (CDC) Cooperative Agreement No. U66\/CCU911165-10."},{"key":"10.1016\/j.vaccine.2012.05.050_bib0200","series-title":"Out of crisis","author":"Deming","year":"1991"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/oxfordjournals.epirev.a036021","article-title":"Public health surveillance in the United States","volume":"10","author":"Thacker","year":"1988","journal-title":"Epidemiol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.050_bib0210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/ije\/22.3.559","article-title":"Ascertainment corrected rates: applications of capture\u2013recapture methods","volume":"22","author":"McCarty","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0215","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/oxfordjournals.aje.a116400","article-title":"The value of capture\u2013recapture methods even for apparent exhaustive surveys: the need for adjustment for source of ascertainment intersection in attempted complete prevalence studies","volume":"135","author":"Hook","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0220","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/0140-6736(92)90639-K","article-title":"Capture\u2013recapture methods","volume":"339","author":"Hook","year":"1992","journal-title":"Lancet"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.05.050_bib0225","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/INF.0b013e3181acf84f","article-title":"Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2007, 2008","volume":"28","author":"Tseng","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0230","series-title":"The Proceedings of the 41st Annual meeting of IDSA","article-title":"A population-based study of herpes zoster (HZ) in children and adolescents post-varicella vaccine licensure","author":"Civen","year":"2003"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0235","series-title":"The 38th National Immunization Conference of CDC","article-title":"A population-based study of herpes zoster (HZ) in children and adolescents post-varicella vaccine licensure 2000\u20132003","author":"Civen","year":"2004"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0240","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJM199803053381011","article-title":"Universal vaccination against varicella","volume":"338","author":"Spingarn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0245","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1056\/NEJM199806253382620","article-title":"More on varicella immunization","volume":"338","author":"Wack","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0250","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/148.2.200","article-title":"Immunologic evidence of reinfection with varicella-zoster virus","volume":"148","author":"Arvin","year":"1983","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.050_bib0255","doi-asserted-by":"crossref","first-page":"908","DOI":"10.11150\/kansenshogakuzasshi1970.69.908","article-title":"Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster","volume":"69","author":"Terada","year":"1995","journal-title":"Kansenshogaku Zasshi"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.05.050_bib0260","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/infdis\/173.2.450","article-title":"The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox","volume":"173","author":"Gershon","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0265","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0190-9622(98)70207-5","article-title":"Lasting immunity to varicella in doctors study (L.I.V.I.D. study)","volume":"38","author":"Solmon","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"August (9334)","key":"10.1016\/j.vaccine.2012.05.050_bib0270","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case\u2013control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"issue":"October (44)","key":"10.1016\/j.vaccine.2012.05.050_bib0275","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1016\/j.vaccine.2011.08.023","article-title":"Contacts with children and young people and adult risk of suffering herpes zoster","volume":"29","author":"Salleras","year":"2011","journal-title":"Vaccine"},{"issue":"January (51)","key":"10.1016\/j.vaccine.2012.05.050_bib0280","first-page":"Q1","volume":"55","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2012.05.050_bib0285","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"van Hoek","year":"2011","journal-title":"Vaccine"},{"issue":"October (41)","key":"10.1016\/j.vaccine.2012.05.050_bib0290","first-page":"Q1","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"June (19\u201320)","key":"10.1016\/j.vaccine.2012.05.050_bib0295","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.05.050_bib0300","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/adc.88.10.862","article-title":"Varicella vaccination in England and Wales: cost-utility analysis","volume":"88","author":"Brisson","year":"2003","journal-title":"Arch Dis Child"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.05.050_bib0305","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/591975","article-title":"Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States","volume":"29","author":"Patel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"June (1)","key":"10.1016\/j.vaccine.2012.05.050_bib0310","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2458-5-68","article-title":"The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998\u20132003","volume":"5","author":"Yih","year":"2005","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0315","unstructured":"Civen R, Mascola L. 2006, 2007 Annual Summary, Antelope Valley Varicella Active Surveillance Project (VASP), Los Angeles County Department of Health Services (LADHS), Centers for Disease Control and Prevention (CDC) Cooperative Agreement No. U66\/CCU911165-10."},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.05.050_bib0320","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2012.05.050_bib0325","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/651078","article-title":"Increasing incidence of herpes zoster among veterans","volume":"50","author":"Rimland","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.05.050_bib0330","first-page":"16","article-title":"Herpes zoster, active component, U.S. Armed Forces, 2000\u20132010","volume":"18","author":"Cockrill","year":"2011","journal-title":"Med Surveill Mon Rep"},{"issue":"May (17)","key":"10.1016\/j.vaccine.2012.05.050_bib0335","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.287.17.2211","article-title":"Varicella vaccine and shingles","volume":"287","author":"Brisson","year":"2002","journal-title":"JAMA"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2012.05.050_bib0340","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992\u20132002","volume":"191","author":"Jumaan","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2012.05.050_bib0345","first-page":"567","article-title":"Surveillance of viral pathogens in Australia\u2014varicella-zoster virus","volume":"26","author":"Roche","year":"2002","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0350","series-title":"National Center for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS)","author":"Burgess","year":"2002"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.05.050_bib0355","first-page":"658","article-title":"Herpes zoster in Australia: evidence of increase in incidence in adults attributable to varicella immunization?","volume":"139","author":"Jardine","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2012.05.050_bib0360","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5694\/j.1326-5377.2010.tb04009.x","article-title":"Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine","volume":"193","author":"Grant","year":"2010","journal-title":"Med J Aust"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2012.05.050_bib0365","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster virus infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0370","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.1994.03510290057037","article-title":"Cost-effectiveness of a routine varicella vaccination program for US children","volume":"271","author":"Lieu","year":"1994","journal-title":"JAMA"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0375","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bulm.1999.0126","article-title":"Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles","volume":"61","author":"Schuette","year":"1999","journal-title":"Bull Math Biol"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0380","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S0950268800050019","article-title":"The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster","volume":"108","author":"Garnett","year":"1992","journal-title":"Epidemiol Infect"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.05.050_bib0385","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","article-title":"An economic analysis of the universal varicella vaccination program in the United States","volume":"197","author":"Zhou","year":"2008","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.05.050_bib0390","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1542\/peds.2010-0962","article-title":"Varicella-related hospitalizations in the United States, 2000\u20132006: the 1 dose varicella vaccination era","volume":"127","author":"Lopez","year":"2011","journal-title":"Pediatrics"},{"issue":"November (51)","key":"10.1016\/j.vaccine.2012.05.050_bib0395","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1016\/j.vaccine.2011.10.022","article-title":"Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy","volume":"29","author":"Pozza","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0400","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/1471-2334-11-352","article-title":"Epidemiological characteristics of varicella for 2000 to 2008 and the impact of nationwide immunization in Taiwan","volume":"December (11)","author":"Chang","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0405","series-title":"Economic evaluation of the universal varicella vaccination program in the US","author":"Zhou","year":"2005"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0410","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1016\/j.vaccine.2003.10.042","article-title":"Cost\u2013benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology","volume":"23","author":"Goldman","year":"2005","journal-title":"Vaccine"},{"issue":"RR11","key":"10.1016\/j.vaccine.2012.05.050_bib0415","first-page":"1","article-title":"Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP)","volume":"45","author":"Centers for Disease Control and Prevention (CDC)","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.05.050_bib0420","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1093\/infdis\/174.Supplement_3.S310","article-title":"Varicella vaccine: the Japanese experience","volume":"174","author":"Asano","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0425","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1542\/peds.81.6.779","article-title":"Combined vaccine against measles, mumps, rubella, and varicella","volume":"81","author":"Brunell","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0430","series-title":"Varicella Virus Vaccine Live. Summary of Basis of Approval. Reference No. 93-0395","author":"U.S. Food and Drug Administration (FDA)","year":"1995"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0435","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"Vazquez","year":"2001","journal-title":"N Engl J Med"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2012.05.050_bib0440","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM198405313102201","article-title":"Live attenuated varicella virus vaccine, efficacy trial in healthy children","volume":"310","author":"Weibel","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0445","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00006454-199912000-00004","article-title":"Post licensure study of varicella vaccine effectiveness in a day-care setting","volume":"18","author":"Clements","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0450","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/340868","article-title":"An outbreak of varicella among children attending preschool and elementary school in Illinois","volume":"35","author":"Dworkin","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2012.05.050_bib0455","first-page":"1102","article-title":"Younger age at vaccination may increase risk of varicella vaccine failure","volume":"186","author":"Galil","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0460","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination","volume":"347","author":"Galil","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0465","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/422041","article-title":"An elementary school outbreak of varicella attributed to vaccine failure: policy implications","volume":"190","author":"Lee","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0470","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMe020138","article-title":"Varicella vaccine\u2014are two doses better than one?","volume":"347","author":"Gershon","year":"2002","journal-title":"N Engl J Med"},{"issue":"3 Pt. 1","key":"10.1016\/j.vaccine.2012.05.050_bib0475","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1542\/peds.113.3.455","article-title":"Chickenpox outbreak in a highly vaccinated school population","volume":"113","author":"Tugwell","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0480","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.292.6.704","article-title":"Contagiousness of varicella in vaccinated cases","volume":"299","author":"Seward","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0485","first-page":"15","article-title":"VZV molecular epidemiology","volume":"342","author":"Breuer","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2012.05.050_bib0490","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1086\/508539","article-title":"Reactivation of 2 genetically distinct varicella-zoster viruses in the same individual","volume":"43","author":"Taha","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2012.05.050_bib0495","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1086\/592452","article-title":"Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine","volume":"198","author":"Levin","year":"2008","journal-title":"J Infect Dis"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2012.05.050_bib0500","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1086\/527419","article-title":"Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004","volume":"197","author":"Lopez","year":"2008","journal-title":"J Infect Dis"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0505","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0002-9394(99)00059-8","article-title":"Uveitis associated with varicella virus vaccine","volume":"127","author":"Esmaeli-Gutstein","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0510","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0002-9394(02)01957-8","article-title":"Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination","volume":"135","author":"Naseri","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0515","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaapos.2005.06.009","article-title":"Herpes zoster ophthalmicus in an otherwise-healthy child","volume":"9","author":"Binder","year":"2005","journal-title":"J AAPOS"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0520","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/bjo.2008.144501","article-title":"Acute posterior multifocal placoid pigment epitheliopathy following varicella vaccine","volume":"94","author":"Fine","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.05.050_bib0525","doi-asserted-by":"crossref","first-page":"e969","DOI":"10.1542\/peds.2009-2633","article-title":"Vaccine-associated herpes zoster ophthalmicus and encephalitis in an immunocompetent child","volume":"125","author":"Chouliaras","year":"2010","journal-title":"Pediatrics"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.05.050_bib0530","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archophthalmol.2010.142","article-title":"Exacerbation of zoster interstitial keratitis after zoster vaccination in an adult","volume":"128","author":"Khalifa","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2012.05.050_bib0535","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09273940802491892","article-title":"Herpes zoster keratouveitis and inflammatory ocular hypertension 8 years after varicella vaccination","volume":"17","author":"Lin","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.05.050_bib0540","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/archophthalmol.2008.569","article-title":"Interstitial keratitis following varicella vaccination","volume":"127","author":"Nagpal","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.vaccine.2012.05.050_bib0545","first-page":"1465","article-title":"Morphological changes in the central nervous system in post-vaccinal encephalomyelitis developing after chickenpox vaccination in children","volume":"70","author":"Ravkina","year":"1970","journal-title":"Zh Nevropatol Psikhiatr Im S S Korsakova"},{"issue":"November (4)","key":"10.1016\/j.vaccine.2012.05.050_bib0550","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0887-8994(95)00194-8","article-title":"Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination","volume":"13","author":"Sunaga","year":"1995","journal-title":"Pediatr Neurol"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2012.05.050_bib0555","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1442-200X.1993.tb03067.x","article-title":"Varicella infection complicated with meningitis after immunization","volume":"35","author":"Naruse","year":"1993","journal-title":"Acta Paediatr Jpn"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2012.05.050_bib0560","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1542\/peds.114.2.e273","article-title":"Varicella zoster virus meningitis in a previously immunized child","volume":"114","author":"Schwab","year":"2004","journal-title":"Pediatrics"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0565","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/INF.0b013e3181f63cf9","article-title":"Herpes zoster and meningitis due to reactivation of varicella vaccine virus in an immunocompetent child","volume":"30","author":"Han","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0570","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.annemergmed.2008.10.023","article-title":"Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child","volume":"53","author":"Iyer","year":"2009","journal-title":"Ann Emerg Med"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2012.05.050_bib0575","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcv.2010.04.014","article-title":"VZV meningitis following varicella vaccine","volume":"48","author":"Fusco","year":"2010","journal-title":"J Clin Virol"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2012.05.050_bib0580","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/378502","article-title":"Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus: in an immunosuppressed child","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.05.050_bib0585","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1086\/522161","article-title":"Safety of varicella vaccine after licensure in the United States; experience from reports to the vaccine adverse event reporting system 1995\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.05.050_bib0590","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J Infect Dis"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0595","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/infdis\/jiq066","article-title":"Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine","volume":"203","author":"Pahud","year":"2011","journal-title":"J Infect Dis"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2012.05.050_bib0600","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0264-410X(98)00209-6","article-title":"Urticaria following varicella vaccine associated with gelatin allergy","volume":"17","author":"Singer","year":"1999","journal-title":"Vaccine"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2012.05.050_bib0605","doi-asserted-by":"crossref","first-page":"833","DOI":"10.7326\/0003-4819-126-10-199705150-00036","article-title":"Allergic reaction to varicella vaccine","volume":"126","author":"Gerecitano","year":"1997","journal-title":"Ann Intern Med"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0610","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.inf.0000154330.47509.42","article-title":"Recurrent papular urticaria after varicella immunization in a 15-month-old girl","volume":"24","author":"Bronstein","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"Spring (1)","key":"10.1016\/j.vaccine.2012.05.050_bib0615","first-page":"78","article-title":"Thrombocytopenic purpura following varicella-zoster vaccination","volume":"8","author":"Lee","year":"1986","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2012.05.050_bib0620","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1442-200X.1995.tb03396.x","article-title":"Herpes zoster in a normal child after varicella vaccination","volume":"37","author":"Matsubara","year":"1995","journal-title":"Acta Paediatr Jpn"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0625","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/infdis\/160.3.535","article-title":"Herpes zoster in an adult recipient of live attenuated varicella vaccine","volume":"160","author":"Hammerschlag","year":"1989","journal-title":"J Infect Dis"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.05.050_bib0630","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00431-002-0981-1","article-title":"Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child","volume":"161","author":"Uebe","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.05.050_bib0635","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/00006454-199912000-00023","article-title":"Natural varicella-zoster virus reactivation shortly after varicella immunization in a child","volume":"18","author":"Kohl","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.05.050_bib0640","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/infdis\/159.5.1000","article-title":"Zoster in normal children after varicella vaccine","volume":"159","author":"Plotkin","year":"1989","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2012.05.050_bib0645","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/00365540701762449","article-title":"Breakthrough VZV infection after immunization: presenting as herpes zoster","volume":"40","author":"Cornelissen","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.05.050_bib0650","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/INF.0b013e318170af75","article-title":"Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old","volume":"27","author":"Ota","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.05.050_bib0655","first-page":"51","article-title":"Hip pain as initial presentation for varicella-zoster infection in an adolescent male","volume":"34","author":"Micucci","year":"2011","journal-title":"Orthopedics"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0660","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jpeds.2004.08.005","article-title":"Stroke after varicella vaccination","volume":"146","author":"Wirrell","year":"2004","journal-title":"J Pediatr"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0665","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jpeds.2006.01.038","article-title":"Secondary transmission of varicella vaccine virus in a chronic care facility for children","volume":"148","author":"Grossberg","year":"2006","journal-title":"J Pediatr"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.05.050_bib0670","first-page":"905","article-title":"Transmission of varicella to a gravida via close contacts immunized with varicella-zoster vaccine. A case report","volume":"44","author":"Huang","year":"1999","journal-title":"J Reprod Med"},{"issue":"July (1 Pt. 1)","key":"10.1016\/j.vaccine.2012.05.050_bib0675","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-3476(97)70140-9","article-title":"Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother","volume":"131","author":"Salzman","year":"1997","journal-title":"J Pediatr"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2012.05.050_bib0680","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2010.11.071","article-title":"Transmission of varicella vaccine virus to a non-family member in China","volume":"29","author":"Gan","year":"2011","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.05.050_bib0685","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1086\/503503","article-title":"Chickenpox and pneumonia following varicella vaccine","volume":"25","author":"Lohiya","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"October (9)","key":"10.1016\/j.vaccine.2012.05.050_bib0690","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1034\/j.1600-6143.2002.20912.x","article-title":"Varicella infection following varicella vaccination in a liver transplant recipient","volume":"2","author":"Levitsky","year":"2002","journal-title":"Am J Transplant"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.05.050_bib0695","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/j.ijid.2011.03.016","article-title":"Varicella rates among unvaccinated and one-dose healthy children in Izmir, Turkey","volume":"15","author":"Kurugol","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"April (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0700","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajic.2010.06.027","article-title":"Vaccine-related varicella zoster rash in a hospitalized immunocompetent patient","volume":"39","author":"Bernstein","year":"2011","journal-title":"Am J Infect Control"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2012.05.050_bib0705","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s15010-006-5616-9","article-title":"Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination","volume":"34","author":"Ludwig","year":"2006","journal-title":"Infection"},{"issue":"September (37\u201338)","key":"10.1016\/j.vaccine.2012.05.050_bib0710","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2007.07.010","article-title":"Metaanalysis of vaccine effectiveness in varicella outbreaks","volume":"25","author":"Bayero","year":"2007","journal-title":"Vaccine"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2012.05.050_bib0715","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5694\/mja11.11484","article-title":"Stevens\u2013Johnson syndrome after varicella vaccination","volume":"194","author":"Christou","year":"2012","journal-title":"Med J Aust"},{"issue":"April","key":"10.1016\/j.vaccine.2012.05.050_bib0720","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(07)60567-4","article-title":"Varicella vaccination in a child with acute lymphoblastic leukaemia","volume":"369","author":"Schrauder","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2012.05.050_bib0725","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1155\/S1064744902000169","article-title":"Varicella vaccination during early pregnancy: a cause of in utero miliary fetal tissue calcifications and hydrops?","volume":"10","author":"Apuzzio","year":"2002","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.05.050_bib0730","first-page":"1328","article-title":"Bullous pemphigoid after herpes zoster vaccine administration: association or coincidence?","volume":"10","author":"Chac\u00f3n","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.05.050_bib0735","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0091-6749(97)70108-8","article-title":"IgE-mediated systemic reactions to gelatin included in the varicella vaccine","volume":"99","author":"Sakaguchi","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.05.050_bib0740","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/INF.0b013e31816fc323","article-title":"Large injection site reactions after a second dose of varicella vaccine","volume":"27","author":"Walter","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2012.05.050_bib0745","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5694\/j.1326-5377.2009.tb02498.x","article-title":"Prolonged varicella viraemia and streptococcal toxic shock syndrome following varicella vaccination of a health care worker","volume":"190","author":"Italiano","year":"2009","journal-title":"Med J Aust"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.05.050_bib0750","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/INF.0b013e31819c1041","article-title":"An outbreak of varicella in elementary schoolchildren with two-dose varicella vaccine recipients\u2014Arkansas, 2006","volume":"28","author":"Gould","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.05.050_bib0755","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/INF.0b013e31819b6c1f","article-title":"Aplastic anemia following varicella vaccine","volume":"28","author":"Angelini","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"June (22)","key":"10.1016\/j.vaccine.2012.05.050_bib0760","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"November","key":"10.1016\/j.vaccine.2012.05.050_bib0765","first-page":"1","article-title":"Live attenuated varicella-zoster vaccine: is it worth it?","volume":"10","author":"Skootsky","year":"2006","journal-title":"Proc UCLA Healthc"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2012.05.050_bib0770","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF03405246","article-title":"Estimating the number needed to vaccinate to prevent herpes zoster-related disease, health care resource use and mortality","volume":"99","author":"Brisson","year":"2008","journal-title":"Can J Public Health"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.05.050_bib0775","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm1715","article-title":"Differential regulation of central nervous system autoimmunity by TH1 andTH17 cells","volume":"24","author":"Stromnes","year":"2008","journal-title":"Nat Med"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.05.050_bib0780","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/1523-1747.ep12470172","article-title":"The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin","volume":"88","author":"Bos","year":"1987","journal-title":"J Invest Dermatol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2012.05.050_bib0785","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s13365-011-0048-z","article-title":"Cytotoxicity of glioblastoma cells mediated ex vivo by varicella-zoster virus-specific T cells","volume":"17","author":"Canniff","year":"2011","journal-title":"J Neurovirol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.05.050_bib0790","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/aje\/154.2.161","article-title":"Prevalence of antibodies to four herpesviruses among adults with glioma and controls","volume":"154","author":"Wrensch","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.vaccine.2012.05.050_bib0795","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/aje\/kwi119","article-title":"History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls","volume":"161","author":"Wrensch","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"April (10)","key":"10.1016\/j.vaccine.2012.05.050_bib0800","article-title":"Neurological complications of vaccinations. Mealey's Litigation Report","volume":"1","author":"Poser","year":"2003","journal-title":"Thimerosal Vaccin"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2012.05.050_bib0805","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1399-3038.2011.01224.x","article-title":"Chickenpox in childhood is associated with decreased atopic disorders, IgE, allergic sensitization, and leukocyte subsets","volume":"23","author":"Silverberg","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"issue":"October (Suppl. 1)","key":"10.1016\/j.vaccine.2012.05.050_bib0810","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1086\/342963","article-title":"Varicella-zoster virus: atypical presentations and unusual complications","volume":"186","author":"Gnann","year":"2002","journal-title":"J Infect Dis"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0815","doi-asserted-by":"crossref","first-page":"e1070","DOI":"10.1542\/peds.2005-2085","article-title":"One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?","volume":"117","author":"Lopez","year":"2006","journal-title":"Pediatrics"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.05.050_bib0820","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1086\/522134","article-title":"Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement\u2014Maine, 2006","volume":"197","author":"Parker","year":"2008","journal-title":"J Infect Dis"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.05.050_bib0825","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/INF.0b013e31819c1041","article-title":"Varicella outbreaks among 1- and 2-dose vaccine recipients","volume":"28","author":"Gould","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"July (27)","key":"10.1016\/j.vaccine.2012.05.050_bib0830","first-page":"749","article-title":"Varicella outbreak among vaccinated children\u2014Nebraska, 2004","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.05.050_bib0835","series-title":"Chickenpox vaccine losses effectiveness study","year":"2007"},{"issue":"August (6)","key":"10.1016\/j.vaccine.2012.05.050_bib0840","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14760584.7.6.753","article-title":"Cost-effectiveness of varicella vaccination programs: an update of the literature","volume":"7","author":"Rozenbaum","year":"2008","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12007761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12007761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T15:09:32Z","timestamp":1642345772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12007761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":168,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0264410X12007761"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}